Annual Working Capital
$7.04 M
-$3.75 M-34.75%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual working capital is currently $7.04 million, with the most recent change of -$3.75 million (-34.75%) on 31 December 2023. During the last 3 years, it has fallen by -$22.15 million (-75.87%).ACRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$7.04 M
-$3.80 M-35.07%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly working capital is currently $7.04 million, with the most recent change of -$3.80 million (-35.07%) on 31 December 2023. Over the past year, it has dropped by -$3.80 million (-35.07%).ACRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.8% | -35.1% |
| 3 y3 years | -75.9% | -79.7% |
| 5 y5 years | -92.3% | -90.5% |
ACRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -93.4% | -93.9% |
AcelRx Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $7.04 M(-34.8%) | $7.04 M(-35.1%) |
| Sept 2023 | - | $10.85 M(+135.0%) |
| June 2023 | - | $4.62 M(-41.5%) |
| Mar 2023 | - | $7.89 M(-26.9%) |
| Dec 2022 | $10.80 M(-66.2%) | $10.80 M(+21.4%) |
| Sept 2022 | - | $8.89 M(-37.9%) |
| June 2022 | - | $14.31 M(-44.5%) |
| Mar 2022 | - | $25.78 M(-19.4%) |
| Dec 2021 | $31.98 M(+9.5%) | $31.98 M(-7.8%) |
| Sept 2021 | - | $34.68 M(-20.8%) |
| June 2021 | - | $43.78 M(-21.5%) |
| Mar 2021 | - | $55.77 M(+91.0%) |
| Dec 2020 | $29.20 M(-49.7%) | $29.20 M(-6.5%) |
| Sept 2020 | - | $31.24 M(-3.0%) |
| June 2020 | - | $32.19 M(-23.9%) |
| Mar 2020 | - | $42.32 M(-27.1%) |
| Dec 2019 | $58.08 M(-36.9%) | $58.08 M(-21.8%) |
| Sept 2019 | - | $74.24 M(-16.1%) |
| June 2019 | - | $88.53 M(+15.9%) |
| Mar 2019 | - | $76.40 M(-17.0%) |
| Dec 2018 | $92.07 M(+85.0%) | $92.07 M(+78.7%) |
| Sept 2018 | - | $51.53 M(+29.6%) |
| June 2018 | - | $39.75 M(-1.6%) |
| Mar 2018 | - | $40.41 M(-18.8%) |
| Dec 2017 | $49.75 M(-36.9%) | $49.75 M(-11.5%) |
| Sept 2017 | - | $56.20 M(+5.6%) |
| June 2017 | - | $53.21 M(-18.4%) |
| Mar 2017 | - | $65.22 M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $78.86 M(-25.7%) | $78.86 M(-3.1%) |
| Sept 2016 | - | $81.39 M(-3.7%) |
| June 2016 | - | $84.52 M(-11.9%) |
| Mar 2016 | - | $95.99 M(-9.6%) |
| Dec 2015 | $106.17 M(+69.7%) | $106.17 M(-7.4%) |
| Sept 2015 | - | $114.71 M(+185.2%) |
| June 2015 | - | $40.21 M(-19.7%) |
| Mar 2015 | - | $50.06 M(-20.0%) |
| Dec 2014 | $62.57 M(-36.0%) | $62.57 M(-18.0%) |
| Sept 2014 | - | $76.27 M(-9.7%) |
| June 2014 | - | $84.48 M(-5.5%) |
| Mar 2014 | - | $89.36 M(-8.5%) |
| Dec 2013 | $97.69 M(+105.9%) | $97.69 M(+51.3%) |
| Sept 2013 | - | $64.57 M(+179.5%) |
| June 2013 | - | $23.11 M(-34.6%) |
| Mar 2013 | - | $35.35 M(-25.5%) |
| Dec 2012 | $47.44 M(+56.5%) | $47.44 M(+262.9%) |
| Sept 2012 | - | $13.07 M(-43.2%) |
| June 2012 | - | $23.00 M(+4.0%) |
| Mar 2012 | - | $22.12 M(-27.0%) |
| Dec 2011 | $30.30 M(-497.0%) | $30.30 M(+4.5%) |
| Sept 2011 | - | $28.99 M(-17.7%) |
| June 2011 | - | $35.23 M(+12.9%) |
| Mar 2011 | - | $31.19 M(-508.7%) |
| Dec 2010 | -$7.63 M(-210.1%) | -$7.63 M(-381.7%) |
| Sept 2010 | - | $2.71 M(-60.9%) |
| Dec 2009 | $6.93 M(-57.9%) | $6.93 M |
| Dec 2008 | $16.45 M | - |
FAQ
- What is AcelRx Pharmaceuticals annual working capital?
- What is the all time high annual working capital for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals annual working capital year-on-year change?
- What is AcelRx Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly working capital year-on-year change?
What is AcelRx Pharmaceuticals annual working capital?
The current annual working capital of ACRX is $7.04 M
What is the all time high annual working capital for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual working capital is $106.17 M
What is AcelRx Pharmaceuticals annual working capital year-on-year change?
Over the past year, ACRX annual working capital has changed by -$3.75 M (-34.75%)
What is AcelRx Pharmaceuticals quarterly working capital?
The current quarterly working capital of ACRX is $7.04 M
What is the all time high quarterly working capital for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly working capital is $114.71 M
What is AcelRx Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ACRX quarterly working capital has changed by -$3.80 M (-35.07%)